Goldman Sachs analyst Alexander Blostein downgraded Ameriprise to Neutral from Buy with a price target of $476, down from $485. The stock, after rallying 23% year-to-date, offers a more balanced risk/reward amid rising earnings risks and limited room for a further valuation re-rating, the analyst tells investors in a research note. The firm sees downside risks to Ameriprise’s cash revenues, saying its floating balances will reprice lower and net interest income benefits from repricing of fixed maturities at the bank seem less likely amid current forward curves.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
 
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMP:
